|
Ayush Ministry says no
knowledge of the scientific study involved
|
New Delhi(Agencies):
The central government on Monday asked Ramdev’s Patanjali to stop advertising
Ayurvedic COVID therapies without first sharing the details of scientific
studies that have led to the Ayurvedic drugs in question.
Taking note of Patanjali’s claims
about new COVID-19 therapy in Ayurveda, Ayush Ministry said on Monday that it
had no knowledge of the scientific study in question.
“Facts of the claim by Patanjali and details
of the stated scientific study are not known to the Ministry. Patanjali Ayurved
Ltd has been asked to provide at the earliest details of the name and
composition of the medicines being claimed for COVID treatment;
site(s)/hospital(s), where the research study was conducted for COVID-19;
protocol, sample size, Institutional Ethics Committee clearance, Clinical Trial
Registry details and results data of the study and stop advertising/publicising
such claims till the issue is duly examined,” the government said.
Ministry also asked Uttarakhand
Licensing Authority to provide copies of license and product approval details
of the Ayurvedic medicines being claimed for the treatment of COVID -19.
The Ministry further said
Patanjali has been informed that such advertisements of drugs including
Ayurvedic medicines are regulated under the provisions of Drugs and Magic
Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder and the
directives issued by the central government in the wake of COVID-19 outbreak
and Ministry a notification had been issued on April 21 stating the
requirements and manner in which research studies on COVID-19 with Ayush
interventions and medicines should be undertaken.
No comments:
Post a Comment